UroGen Pharma Ltd
URGN
$36.81+0.63%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$1.61B
EV/Sales
N/A
P/E ratio
N/A
FY2025 Revenue
$109.79M
EPS (TTM)
$-1.97
Gross Margin (FY2025)
88.66%
Profit Margin (FY2025)
-139.81%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. Revenue was up 538.6% from 2023-03-31 to 2025-12-31. URGN currently screens at market cap $1.61B.
Use this URGN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full URGN income, balance, and cash tables.
UroGen Pharma Ltd (URGN) is a biotechnology company in the Healthcare sector.
Latest cached UroGen Pharma Ltd (URGN) revenue for Dec 31, 2025 was $109.8M. Net income was -$153.5M. Statements: https://lician.com/financials/urgn
UroGen Pharma Ltd (URGN) market capitalization is $1.61B on the latest cached snapshot.
UroGen Pharma Ltd (URGN) cached previous close $36.58; day range $36.81 – $37.04; volume 190,994. Session quote: https://lician.com/quote/urgn
UroGen Pharma Ltd (URGN) latest cached earnings event is "URGN earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings